CenterBook Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-10,126
Closed -$1.88M 624
2025
Q3
$1.88M Sell
10,126
-71,021
-88% -$12.2M 0.09% 264
2025
Q2
$12.4M Buy
81,147
+39,467
+95% +$6.07M 0.69% 32
2025
Q1
$6.91M Buy
41,680
+3,465
+9% +$542K 0.44% 60
2024
Q4
$5.53M Buy
38,215
+30,314
+384% +$4.7M 0.33% 87
2024
Q3
$1.28M Sell
7,901
-17,612
-69% -$2.81M 0.08% 266
2024
Q2
$3.73M Sell
25,513
-3,240
-11% -$482K 0.23% 171
2024
Q1
$4.55M Buy
28,753
+8,743
+44% +$1.39M 0.31% 118
2023
Q4
$3.14M Buy
20,010
+10,348
+107% +$1.59M 0.38% 80
2023
Q3
$1.5M Sell
9,662
-981
-9% -$162K 0.19% 184
2023
Q2
$1.76M Sell
10,643
-3,715
-26% -$600K 0.22% 163
2023
Q1
$2.23M Sell
14,358
-1,529
-10% -$247K 0.31% 102
2022
Q4
$2.81M Buy
15,887
+5,088
+47% +$879K 0.46% 52
2022
Q3
$1.76M Buy
10,799
+3,438
+47% +$582K 0.34% 89
2022
Q2
$1.31M Buy
7,361
+3,768
+105% +$671K 0.28% 128
2022
Q1
$637K Buy
+3,593
New +$611K 0.23% 164

Other funds holding JNJ

CenterBook Partners's JNJ Position: Q4 2025 in Review

CenterBook Partners sold out of Johnson & Johnson (JNJ) in Q4 2025, closing a stake of 10,126 shares — an estimated $1.88M sold.

CenterBook Partners first reported a position in JNJ in Q1 2022 and held it in 15 quarters. The position peaked at $12.4M in Q2 2025. 4,520 funds tracked by Wall St. Rank hold JNJ as of Q4 2025.

  • CenterBook Partners reported no remaining Johnson & Johnson position as of Q4 2025 after selling out during the quarter.
  • CenterBook Partners sold 10,126 Johnson & Johnson shares in Q4 2025, an estimated $1.88M.
  • CenterBook Partners first reported a position in Johnson & Johnson in Q1 2022 and held it in 15 quarters.
  • CenterBook Partners's Johnson & Johnson position peaked at $12.4M in Q2 2025.
  • 4,520 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2025.

Based on CenterBook Partners's 13F filing for Q4 2025, filed 11 Feb 2026.